IntelGenx: IntelGenx initiates restructuring proceedings
The protection afforded by the CCAA is intended to provide the Company with the time and breathing room necessary to implement a strategic review process.
Read full article »
IntelGenx is a Canada-based drug delivery company that develops novel oral thin film and transdermal drug products for pharmaceutical and animal health markets.
Read more